Swiss National Bank
GBIO

Swiss National Bank’s Generation Bio GBIO Stock Holding History

Swiss National Bank’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,680
Closed -$420K – 2649
2022
Q4 		$420K Buy
10,680
+610
+6% +$32K ﹤0.01% 2601
2022
Q3 		$535K Hold
10,070
– – ﹤0.01% 2542
2022
Q2 		$661K Buy
10,070
+1,330
+15% +$86.9K ﹤0.01% 2541
2022
Q1 		$642K Buy
8,740
+600
+7% +$34.8K ﹤0.01% 2542
2021
Q4 		$576K Hold
8,140
– – ﹤0.01% 2639
2021
Q3 		$2.04M Buy
8,140
+160
+2% +$38.3K ﹤0.01% 2037
2021
Q2 		$2.15M Buy
7,980
+980
+14% +$293K ﹤0.01% 2054
2021
Q1 		$1.99M Buy
7,000
+4,380
+167% +$1.4M ﹤0.01% 2010
2020
Q4 		$743K Buy
+2,620
New +$841K ﹤0.01% 2398

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Swiss National Bank's GBIO Position: Q1 2023 in Review

Swiss National Bank sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 10,680 shares — an estimated $420K sold.

Swiss National Bank first reported a position in GBIO in Q4 2020 and held it in 9 quarters. The position peaked at $2.15M in Q2 2021. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • Swiss National Bank reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 10,680 Generation Bio shares in Q1 2023, an estimated $420K.
  • Swiss National Bank first reported a position in Generation Bio in Q4 2020 and held it in 9 quarters.
  • Swiss National Bank's Generation Bio position peaked at $2.15M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.